Róbert Wessman, Alvotech CEO
January 23, 2023 07:51 AM EST
Financing

Alvotech rais­es $137M months af­ter FDA re­ject­ed Hu­mi­ra biosim­i­lar

Katherine Lewin

News Reporter

Alvotech has com­plet­ed a pri­vate place­ment worth $137 mil­lion at $11.57 per share di­rect­ed on­ly in­to Ice­land, a lit­tle over a month af­ter an­nounc­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times